Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - a direct and selective antagonist

Thromb Haemost. 2004 Dec;92(6):1229-31.

Authors

Richard C Becker, John Alexander, You Fu Li, Edwin Bovill, Frederick A Spencer, Thomas L Robertson, Satoshi Kunitada, Christopher K Dyke, Robert A Harrington

PMID: 15622616

No abstract available

Publication types

Letter

MeSH terms

Anticoagulants / administration & dosage
Anticoagulants / pharmacology*
Blood Coagulation Tests
Calcium Chloride / pharmacology
Camptothecin / administration & dosage
Camptothecin / analogs & derivatives*
Camptothecin / pharmacology*
Drug Synergism
Enoxaparin / pharmacology*
Factor Xa / chemistry
Factor Xa Inhibitors*
Heparin / administration & dosage
Heparin / blood
Heparin / metabolism
Heparin / pharmacology*
Heparin, Low-Molecular-Weight / blood
Humans
Sensitivity and Specificity

Substances

Anticoagulants
Enoxaparin
Factor Xa Inhibitors
Heparin, Low-Molecular-Weight
Heparin
Factor Xa
Calcium Chloride
exatecan
Camptothecin